Renal denervation: Time to open Pandora's box

Swiss Medical Weekly

Volumn 142, Issue JULY, 2012, Pages

  Gu, Yu Mei ^a   Asayama, Kei ^a,b   Liu, Yan Ping ^a   Staessen, Jan A ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b TOHOKU UNIVERSITY   (Japan)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Renal denervation; Sympathetic nervous system; Treatment resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; FEASIBILITY STUDY; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY DENERVATION; NOTE; OBESITY; PATIENT COMPLIANCE; QUALITY OF LIFE; RESISTANT HYPERTENSION; SLEEP APNEA SYNDROME; TREATMENT RESISTANT HYPERTENSION; BLOOD PRESSURE; DRUG RESISTANCE; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; REVIEW; SYMPATHECTOMY;

BLOOD PRESSURE; DRUG RESISTANCE; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 84864544242     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13638     Document Type: Note

References (31)

1. Staessen JA, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA. 2003;289(18):2420-2. (Pubitemid 37430177)
2. Weinehall L, Öhgren B, Persson M, Stegmayr B, Boman K, Hallmans G, et al. High remaining risk in poorly treated hypertension: the "rule of halves" still exist. J Hypertens. 2002;20(10):2081-8. (Pubitemid 35305507)
3. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510-26.
4. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77(1):75-197. (Pubitemid 27069290)
5. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension. Hypertension. 2009;54(5):690-7.
6. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Eng J Med. 2009;361:932-4.
7. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension. Novel implications for an old concept. Hypertension. 2009;54:1195-201.
8. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinsky P, Bielen P, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-65.
9. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-9.
10. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29:991-6.
11. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275-81.
12. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903-9.
13. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension. Durability of blood pressure reduction out to 24 months. Hypertension. 2011;57(5):911-7.
14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-87. (Pubitemid 46924065)
15. Turner MJ, van Schalkwyk J.M. Is it ethical to perform irreversible renal denervation before a trial low sodium intake for treatment-resistant hypertension? Hypertension. 2011;58(2):1-9.
16. Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008;2(6):462-8.
17. Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens. 2004;22(11):2217-26. (Pubitemid 39463817)
18. Young LM, Haakenson CM, Lee KK, van Eeckhout JP. Riboflavin use as a drug marker in Veterans Administration cooperative studies. Control Clin Trials. 1984;5(Suppl 4):497-504. (Pubitemid 15125206)
19. Azizi M, Ménard J, Peyrard S, Lièvre M, Marre M, Chatellier G. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-Acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events and Ramipril (DIABHYCAR) study. Diabet Care. 2006;29:1331-36. (Pubitemid 44125931)
20. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al., on behalf of the International Database on ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO) investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115(16):2145-52.
21. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al., on behalf of the IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populatios: a meta-analasis of 7030 individuals. J Hypertens. 2007;25(18):1554-64. (Pubitemid 47056557)
22. Staessen JA, Thijs L, Ohkubo T, Kikuya M, Richart T, Boggia J, et al. Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit. 2008;13(6):352-65.
23. Pickering TG, Houston Miller N, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring. A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):10-29.
24. Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168(21):2340-6.
25. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol. 2011;100(12):1095-101.
26. Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, Jennings G. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation. 1993;88:1110-8. (Pubitemid 23264028)
27. Johnston SC. Patent foramen ovale closure - closing the door except for trials. N Engl J Med. 2012;366(11):1048-50.
28. Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke. 2012;43:422-31.
29. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991-9.
30. Mark C, Mark DB, Trevor C, David C, John D, Huon G, et al. The Joint UK Societies' consensus statement on renal denervation for resistant hypertension, 2012. Available from: http://www.bhsoc.org/docs/The-Joint-UK-Societies'- Consensus-on-Renal-Denervation-for-resistanthypertension.pdf.
31. Chobanian AV, Bakris GL, Black BK, Cushman WC, Green LA, Izzo JL, et al., and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52. (Pubitemid 37553153)